CS logo
small CS logo
Medical University Reaviz

Samara, Russian Federation
Частный университет в Самаре

About Medical University Reaviz


Медицинский университет «Реавиз» — частный медицинский университет, реализующий высшее и последипломное образование в городах Самара, Москва, Санкт-Петербург, Саратов. Имеет представительство в г. Бургас. Основан в 1993 году. Выдаёт дипломы и свидетельства о медицинском образовании государственного образца.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Medical University Reaviz


During the past decade, Medical University Reaviz conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 6 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Medical University Reaviz" #1 sponsor was "Shire" with 5 trials, followed by "Celgene" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

Clinical Trials Conditions at Medical University Reaviz


According to Clinical.Site data, the most researched conditions in "Medical University Reaviz" are "Ulcerative Colitis" (7 trials), "Crohn's Disease" (5 trials), "Crohn Disease" (3 trials), "Advanced Malignancies" (1 trials) and "Chemotherapy-induced Neutropenia" (1 trials). Many other conditions were trialed in "Medical University Reaviz" in a lesser frequency.

Clinical Trials Intervention Types at Medical University Reaviz


Most popular intervention types in "Medical University Reaviz" are "Drug" (18 trials), "Other" (6 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Ontamalimab" (4 trials), "Ozanimod" (3 trials), "Guselkumab" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Medical University Reaviz


The vast majority of trials in "Medical University Reaviz" are 20 trials for "All" genders.

Clinical Trials Status at Medical University Reaviz


Currently, there are NaN active trials in "Medical University Reaviz". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Medical University Reaviz, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Medical University Reaviz, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".